Toronto Dominion Bank Decreases Holdings in CME Group Inc. (NASDAQ:CME)

Toronto Dominion Bank trimmed its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 11.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 208,849 shares of the financial services provider's stock after selling 25,716 shares during the quarter. Toronto Dominion Bank owned approximately 0.06% of CME Group worth $48,300,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the stock. New Age Alpha Advisors LLC increased its stake in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after buying an additional 43 shares during the period. Avidian Wealth Enterprises LLC boosted its holdings in CME Group by 2.6% in the fourth quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider's stock valued at $411,000 after acquiring an additional 45 shares during the last quarter. TFC Financial Management Inc. boosted its holdings in CME Group by 8.4% in the fourth quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider's stock valued at $137,000 after acquiring an additional 46 shares during the last quarter. Waldron Private Wealth LLC increased its position in CME Group by 2.0% during the 4th quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider's stock valued at $549,000 after purchasing an additional 47 shares during the period. Finally, Venturi Wealth Management LLC raised its holdings in CME Group by 12.1% during the 4th quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider's stock worth $101,000 after purchasing an additional 47 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CME. Morgan Stanley increased their price objective on shares of CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research report on Thursday, April 24th. Bank of America increased their price target on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. Raymond James raised CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a research note on Monday, March 10th. Keefe, Bruyette & Woods upped their target price on CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research report on Thursday, April 24th. Finally, Piper Sandler lifted their target price on CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a report on Tuesday, April 8th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $256.80.

Insider Activity

In related news, insider Derek Sammann sold 4,650 shares of the firm's stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the transaction, the insider now directly owns 8,336 shares of the company's stock, valued at $2,339,164.96. This trade represents a 35.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Howard J. Siegel sold 10,000 shares of the stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the completion of the sale, the director now owns 21,873 shares of the company's stock, valued at approximately $5,686,980. This trade represents a 31.37% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,884 shares of company stock worth $7,389,843 over the last 90 days. 0.30% of the stock is currently owned by corporate insiders.

CME Group Stock Up 1.4%

Shares of CME Group stock traded up $3.87 during trading hours on Wednesday, reaching $281.74. The company's stock had a trading volume of 2,220,835 shares, compared to its average volume of 2,183,065. The company has a market capitalization of $101.53 billion, a P/E ratio of 29.14, a P/E/G ratio of 6.76 and a beta of 0.45. The stock's fifty day simple moving average is $266.65 and its two-hundred day simple moving average is $247.92. CME Group Inc. has a one year low of $190.70 and a one year high of $286.48. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The firm's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.50 EPS. On average, research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.77%. The ex-dividend date is Monday, June 9th. CME Group's dividend payout ratio (DPR) is presently 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.